SYNCOM FORMULATIONS (INDIA)
Back to Cashflow Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-51 Cr | ₹-18 Cr | ₹83 Cr | ₹-45 Cr | ₹-27 Cr |
What is the latest Cash Flow from Investing Activities ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2026 | ₹-51 Cr |
| Mar2025 | ₹-18 Cr |
| Mar2024 | ₹83 Cr |
| Mar2023 | ₹-45 Cr |
| Mar2022 | ₹-27 Cr |
How is Cash Flow from Investing Activities of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-51 Cr | Negative | |
| Mar2025 | ₹-18 Cr | Negative | |
| Mar2024 | ₹83 Cr | Positive | |
| Mar2023 | ₹-45 Cr | Negative | |
| Mar2022 | ₹-27 Cr | - | |
Compare Cash Flow from Investing Activities of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹2,094.3 Cr | -10.7% | 15.3% | 41.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,466.0 Cr | -0.8% | -5.1% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,222.0 Cr | -3.2% | -1.4% | 53.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | -1.6% | -6% | 32.1% | Stock Analytics | |
| CIPLA | ₹107,447.0 Cr | 0% | -3.6% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,471.0 Cr | 3.1% | 8.7% | -1.5% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -10.7% |
15.3% |
41.8% |
| SENSEX | -0.1% |
-2.3% |
-10.7% |
You may also like the below Video Courses